Loading insider details...
Beta
Latest Form 4 (Aug 3, 2026): Grant/Award of 875 ALT shares, $2.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 875 | $2.1K |
| Feb 27, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 222,670 | n/a |
| Feb 3, 2026 | Altimmune, Inc. (ALT) | Exercise/Conversion | 9,275 | n/a |
| Jan 29, 2026 | Altimmune, Inc. (ALT) | Exercise/Conversion | 15,850 | n/a |
| Jan 27, 2026 | Altimmune, Inc. (ALT) | Exercise/Conversion | 14,600 | n/a |
| Aug 4, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 846 | $2.7K |
| Feb 4, 2025 | Altimmune, Inc. (ALT) | Exercise/Conversion | 9,275 | n/a |
| Jan 29, 2025 | Altimmune, Inc. (ALT) | Exercise/Conversion | 14,600 | n/a |
| Aug 1, 2024 | Altimmune, Inc. (ALT) | Grant/Award | 650 | $3.5K |
| Feb 5, 2024 | Altimmune, Inc. (ALT) | Exercise/Conversion | 6,166 | n/a |